Literature DB >> 2154553

Acetylcholinesterase in cocultures of rat myotubes and spinal cord neurons: effects of collagenase and cis-hydroxyproline on molecular forms, intra- and extracellular distribution, and formation of patches at neuromuscular contacts.

F M Vallette1, S De la Porte, J Koenig, J Massoulié, M Vigny.   

Abstract

Cultures of rat myotubes from 18-day-old embryos produce both globular (G) and asymmetric (A) forms of acetylcholinesterase (AChE; EC 3.1.1.7), mostly G1, G4, and A12 and a small proportion of A8. We show that all forms are partly intracellular and partly exposed to the extracellular medium; the A forms and their intra- and extracellular distribution are not modified when myotubes are grown in the presence of spinal cord neurons. In these cocultures, however, AChE patches may be detected immunohistochemically at sites of neuromuscular contacts. These patches represent a very minor proportion of AChE activity. We found that collagenase removes AChE patches but not the acetylcholine receptor clusters with which they coincide. This digestion specifically decreases the level of the A12 form. cis-Hydroxyproline, an inhibitor of collagen synthesis, reduces the level of G1 and blocks the synthesis of A forms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154553     DOI: 10.1111/j.1471-4159.1990.tb02338.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  2 in total

1.  Limiting role of protein disulfide isomerase in the expression of collagen-tailed acetylcholinesterase forms in muscle.

Authors:  Carlos A Ruiz; Richard L Rotundo
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

2.  Distinct localization of collagen Q and PRiMA forms of acetylcholinesterase at the neuromuscular junction.

Authors:  Véronique Bernard; Emmanuelle Girard; Anna Hrabovska; Shelley Camp; Palmer Taylor; Benoit Plaud; Eric Krejci
Journal:  Mol Cell Neurosci       Date:  2010-09-29       Impact factor: 4.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.